Acotiamide vs itopride for post-meal fullness
Part of Digestive system clinical trials.
This trial compares two medicines, acotiamide and itopride, to see which works better for postprandial distress syndrome—a digestive problem where you feel uncomfortably full after eating. If you have this condition, you may be eligible to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You need a doctor's diagnosis of postprandial distress syndrome using Rome IV criteria.
- You must have had a normal upper endoscopy (camera test of your stomach) within the past 6 months.
- You cannot have taken acotiamide or itopride in the last 2 weeks.
- You must not have diabetes or other chronic conditions like thyroid, kidney, or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called itopride to see if it helps people with functional dyspepsia, a condition that causes stomach pain or fullness after eating. If you have this condition, the medicine might reduce your symptoms.
This trial tests whether cognitive behavioral therapy (CBT) — a type of talk therapy that helps change thoughts and behaviors — can ease the stomach pain and discomfort of functional dyspepsia. You'll also provide samples for research, which may help understand how this condition works.
This study tests a Chinese herbal granule (Lianxiaxiaopi) for people with postprandial distress syndrome, a condition where you feel full too soon or uncomfortably full after eating. The goal is to see if it helps reduce these symptoms.
This study compares two medicines, acotiamide and itopride, to see which works better for people with indigestion (a feeling of fullness after meals). If you have chronic post-meal fullness, you may find relief with one of these treatments.
This study compares two medications that help empty the stomach faster (itopride and metoclopramide) to see which works better for hospital patients with a high amount of leftover stomach contents while on tube feeding. If you qualify, you may receive one of these medications to help with digestion.
This trial tests if a new stomach acid blocker (vonoprazan) works better alone or with a medicine that helps stomach movement (itopride) for people with ongoing stomach discomfort. It aims to find a better treatment for functional dyspepsia.
Hear when a new Postprandial Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.